The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer

View/Open

UoP_Deposit_Agreement v1.1 20160217.pdf (125.4Kb)

da Motta LL, Oncogene 2016.pdf (3.387Mb)

Date

2016-06-13

Author

da Motta, LL

Ledaki, I

Purshouse, K

Haider, S

De Bastiani, MA

Baban, D

Morotti, M

Steers, G

Wigfield, S

Bridges, E

Li, J-L

Knapp, S

Ebner, D

Klamt, F

Harris, AL

McIntyre, A

Metadata

Show full item record

URI

http://hdl.handle.net/10026.1/5259

DOI

http://dx.doi.org/10.1038/onc.2016.184

Collections

• Medicine Dentistry and Health

Journal

Oncogene